Filer Snapshot

Kevin Kotler

CIK 0001601692. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

3

Latest filing

17 Feb 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13F-HR for Q4 2025. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Latest 13F portfolio

$135.37M

34 holdings for Q4 2025

Open portfolio

Largest parsed holding

ANGO

$22M reported value

Open holding

13D/G large stake

ANGO

06 Jan 2026 · 5.9% ownership

Open 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Form 13F

13F-HR filed on 17 Feb 2026 for CIK 0001601692.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

13F portfolio$135.37M

Quarterly institutional holdings reported on Form 13F.

Forms 3/4/5 positions$1.24M

Reporting-owner positions with enough filing detail to estimate value.

Latest reported 13F value

13F
$135.37M

Reported market value from the latest parsed Form 13F information table; this is not total assets under management.

Forms 3/4/5 position value

3/4/5
$1.24M

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Largest 13F holdings

13F
ANGO AUPH AVDL OMER NPCE
+15 moreMDWD AXGN IART ACRS EVTL OSUR GLPG LLY CERS NKE TECX CLYM TMCI TLSI DXCM

Largest symbols in the latest parsed Form 13F information table.

Largest linked holdings

Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.

HRTX

Largest 13F holdings

Largest symbols in the latest parsed Form 13F information table.

ANGO AUPH AVDL OMER NPCE MDWD AXGN IART
+12 moreACRS EVTL OSUR GLPG LLY CERS NKE TECX CLYM TMCI TLSI DXCM

Largest active 13G stakes

Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.

ANGO
How to read these SEC ownership signals
  • Read each filing family separately: 13F portfolios, 13D/G large stakes, and Forms 3/4/5 owner positions answer different SEC disclosure questions.
  • Open the linked research path when you need the filing, CIK, issuer, or CUSIP trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
C/O Broadfin Holdings, Llc, 200 Broadhollow Road, Suite 207, Melville, NY, 11747

Filer intelligence

What SEC filings say about Kevin Kotler

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Latest parsed 13F shows $135.37M across 34 reported holdings for Q4 2025.
  • Largest parsed 13F holding: ANGO at $22M.
  • 1 recent 13D/G stake row found; top row is ANGO at 5.9% ownership.
  • Forms 3/4/5 show insider context for HRTX worth $1.24M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio 34 rows

Quarterly institutional portfolio holdings.

Open
13D/G stakes 1 rows

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 2 rows

Officer, director, and 10% owner holdings or transactions.

Open

Top parsed 13F holdings

Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.

Q4 2025 - 17 Feb 2026

Top 5 concentration

61%

Share of latest parsed 13F value represented by the visible holdings below.

Top 5 reported value

$82.81M

Compared with $135.37M total 13F value.

Top 5 net change

$0

Position-value change inside the visible top holdings only.

13F concentration map

A simple visual split of the latest parsed 13F portfolio.

ANGO AUPH AVDL OMER NPCE Other holdings

ANGO

16.3%

Angiodynamics Inc

$22M

AUPH

14.4%

Aurinia Pharmaceuticals Inc

$19.54M

AVDL

11.8%

Avadel Pharmaceuticals Plc

$15.98M

OMER

11.5%

Omeros Corp

$15.55M

NPCE

7.2%

Neuropace Inc

$9.75M

13D/G large-stake context

ANGO

06 Jan 2026 · Common Stock, par value $.01

5.9%

Forms 3/4/5 insider context

HRTX

22 Feb 2023

$1.24M

BDSI

22 Mar 2022

Latest update

What changed recently for Kevin Kotler

New filing available

Latest 13F period: Q4 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

17 Feb 2026

Page type

Filer profile

Latest period

Q4 2025

Institutional portfolio context was refreshed from a 13F filing filed on 17 Feb 2026.

SEC filing record

CIK 0001601692 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
3
First seen
02 Mar 2023
Latest filing
17 Feb 2026
Entity
Individual

Latest Filings

Showing the latest 3 of 3 SEC filings for Kevin Kotler.

13F-HR

13F-HR filing

Filing date
17 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
09 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 Mar 2023
Reporting date
22 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .